3.20 USD
↘ 0.36 (10.10%)AT CLOSE (03:59 PM EST)
Verrica Pharmaceuticals Inc. Common Stock (VRCA) trades at $3.16 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Strong Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place VRCA at a fair price relative to peers.
Technical & fundamental data as of Nov 16, 2026.